NM_001184880.2:c.513C>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PM1PP2PP3BS2

The NM_001184880.2(PCDH19):​c.513C>G​(p.Asn171Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,095,979 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. N171N) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 25)
Exomes 𝑓: 0.0000055 ( 0 hom. 3 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

3
5
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.527

Publications

0 publications found
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PCDH19 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 9
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_001184880.2
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 107 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Gene score misZ: 2.5929 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Dravet syndrome, developmental and epileptic encephalopathy, 9, X-linked complex neurodevelopmental disorder.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.806
BS2
High AC in GnomAdExome4 at 6 AD,XL,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH19NM_001184880.2 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 6 ENST00000373034.8 NP_001171809.1 Q8TAB3-1
PCDH19NM_001105243.2 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 5 NP_001098713.1 Q8TAB3-2B3KU71
PCDH19NM_020766.3 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 5 NP_065817.2 Q8TAB3-3B3KU71

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 6 1 NM_001184880.2 ENSP00000362125.4 Q8TAB3-1
PCDH19ENST00000255531.8 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 5 1 ENSP00000255531.7 Q8TAB3-2
PCDH19ENST00000420881.6 linkc.513C>G p.Asn171Lys missense_variant Exon 1 of 5 1 ENSP00000400327.2 Q8TAB3-3

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
AF:
0.00000547
AC:
6
AN:
1095979
Hom.:
0
Cov.:
33
AF XY:
0.00000828
AC XY:
3
AN XY:
362299
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26402
American (AMR)
AF:
0.00
AC:
0
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38300
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000712
AC:
6
AN:
842117
Other (OTH)
AF:
0.00
AC:
0
AN:
46079
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
25

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jun 14, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed in large population cohorts (Lek et al., 2016); The majority of missense variants in this gene are considered pathogenic [(Stenson et al., 2014; other references)]; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.83
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.24
.;T;.
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Benign
0.054
D
MetaRNN
Pathogenic
0.81
D;D;D
MetaSVM
Benign
-0.66
T
MutationAssessor
Uncertain
2.6
M;M;M
PhyloP100
-0.53
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-4.5
D;D;D
REVEL
Benign
0.26
Sift
Uncertain
0.0020
D;D;D
Sift4G
Uncertain
0.010
D;D;D
Polyphen
0.95, 0.39
.;P;B
Vest4
0.69
MutPred
0.67
Gain of ubiquitination at N171 (P = 0.0138);Gain of ubiquitination at N171 (P = 0.0138);Gain of ubiquitination at N171 (P = 0.0138);
MVP
0.69
MPC
2.0
ClinPred
0.99
D
GERP RS
-4.9
Varity_R
0.96
gMVP
0.84
Mutation Taster
=15/85
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749602848; hg19: chrX-99663083; API